Nat Genet. Volume 47, Issue 8: p.864-871, 29 June 2015 10.1038/ng.3333
The majority of patients with neuroblastoma have tumors that initially respond to chemotherapy, but a large proportion will experience therapy-resistant relapses. The molecular basis of this aggressive phenotype is unknown. Whole-genome sequencing of 23 paired diagnostic and relapse neuroblastomas showed clonal evolution from the diagnostic tumor, with a median of 29 somatic mutations unique to the relapse sample. Eighteen of the 23 relapse tumors (78%) showed mutations predicted to activate the RAS-MAPK pathway. Seven of these events were detected only in the relapse tumor, whereas the others showed clonal enrichment. In neuroblastoma cell lines, we also detected a high frequency of activating mutations in the RAS-MAPK pathway (11/18; 61%), and these lesions predicted sensitivity to MEK inhibition in vitro and in vivo. Our findings provide a rationale for genetic characterization of relapse neuroblastomas and show that RAS-MAPK pathway mutations may function as a biomarker for new therapeutic approaches to refractory disease.
In order to access Controlled TARGET NBL data using the links below, users must submit an application for Authorized Access via dbGaP as described on dbGaP’s TARGET Study Page. To begin the application process, please view the information and instructions provided on the dbGaP Authorized Access Login Page under “dbGaP Data Download”.
Supplemental Data
- GDC Manifests
- Controlled-Access Data Download Manifest (11 Files)
- Open-Access Data Download Manifest (23 Files)
- WGS CGI Files Download Manifest (137 Files)
- Copy Number Array
- TARGET NBL Copy number array Level 1 Data (Controlled)
- TARGET NBL Copy number array Level 2 Data (Controlled)
- TARGET NBL Copy number array Level 3 Data
- TARGET NBL Copy number array Design Information
- TARGET NBL Copy number array Metadata
- Gene Expression Array
- TARGET NBL Gene expression array Level 1 Data (Controlled)
- TARGET NBL Gene expression array Level 2 Data (Controlled)
- TARGET NBL Gene expression array Level 3 Data
- TARGET NBL Gene expression array Metadata
- mRNA-Seq
- TARGET NBL RNA-seq Level 3 data
- TARGET NBL RNA-seq Level 3 data (Controlled)
- TARGET NBL RNA-seq Metadata
- miRNA-Seq
- Whole Exome Sequencing
- TARGET NBL WXS Level 3 Data
- TARGET NBL WXS Level 3 Data (Controlled)
- TARGET NBL WXS Metadata
- Methylation Array
- TARGET NBL Methylation array Level 1 Data (Controlled)
- TARGET NBL Methylation array Level 2 Data
- TARGET NBL Methylation array Level 3 Data
- TARGET NBL Methylation array Metadata
- Whole Genome Sequencing
- TARGET NBL WGS Level 3 Data
- TARGET NBL WGS Level 3 Data (Controlled)
- TARGET NBL WGS Level 4 Data
- TARGET NBL WGS Metadata
- Targeted Capture Sequencing
- TARGET NBL Targeted Capture Sequencing Level 3 Data
- TARGET NBL Targeted Capture Sequencing Level 3 Data (Controlled)
- TARGET NBL Targeted Capture Sequencing Design
- TARGET NBL Targeted Capture Sequencing Metadata
- GWAS
- TARGET NBL GWAS Level 2 Data (Controlled)
- Miscellaneous Files
- TARGET NBL Sample Matrices
- TARGET NBL ID Mapping Information
- TARGET NBL CGI Requested Reports (Controlled)
Additional Resources
- OCG TARGET Data Matrix (link is external) Office of Cancer Genomics
- TARGET-NBL at SRA (link is external) NCBI
Instructions for Data Download
Open Access Data
- Download the appropriate manifest file from the publication page
- Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
- GDC DTT ( Download, User's Guide)
- GDC API ( User’s Guide)
Controlled Access Data
- Download the appropriate manifest file from the publication page
- Download a token from the GDC Data Portal
- GDC Data Portal ( Launch, User’s Guide)
- Use the manifest file and token to download data using the GDC DTT or the GDC API
- GDC DTT ( Download, User’s Guide)
- GDC API ( User’s Guide)
For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io.